- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06948370
Development and Evaluation of a Culturally Sensitive Structured Diabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar (PARADIGM-Q)
The PARADIGM-Q Study: Development and Evaluation of a Culturally Sensitive Problem- and AttributesbAsed DIabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar
This study is about helping people in Qatar who have Type 2 Diabetes take better care of their health. Diabetes is a common and growing problem in Qatar, and many people need more support and information to manage it well in their daily lives.
Right now, there is a program called DESMOND in Qatar, but it is only available in a few places and can be expensive to run. It also doesn't always work well in the long term. That's why we are creating a new diabetes education program called PARADIGM-Q. This program will be easier to access, more affordable, and designed to match the culture and needs of people living in Qatar.
The PARADIGM-Q program will teach people how to manage diabetes using real-life examples and group discussions. This method is called Case-Based Learning. It helps people understand their condition better and learn how to make good decisions about food, exercise, medication, and dealing with challenges.
The project will happen in two main phases:
Phase One: Understanding and Creating the Program
In the first part, we'll look at different ways of teaching about diabetes and see if a method called Case-Based Learning (CBL) works well. After that, we'll build a curriculum (a plan for teaching) based on the PARADIGM model. This curriculum, called the PARADIGM-Q program, will use the CBL method to teach. We'll also test this new program with a small group of diabetes educators and people with diabetes to make sure it works well. Their feedback will help me make the program even better.
Phase Two: Testing the Program
In the second part, we'll do a big study using a mix of people from different backgrounds in Qatar who have Type 2 Diabetes. we want to see if the PARADIGM-Q program is better than the program they already have (called DESMOND). we'll look the impact of our new program on different things like how much they know about diabetes, how active they are, their blood sugar levels (HbA1C), and their overall quality of life.
This study could lead to a new standard for diabetes education in Qatar and other countries in the region, helping more people live healthier lives with diabetes.
Study Overview
Status
Detailed Description
This PhD research project aims to develop and evaluate a culturally sensitive Diabetes Self-Management Education (DSME) program, the PARADIGM-Q, specifically tailored for people with Type 2 Diabetes Mellitus (T2DM) residing in Qatar. With T2DM reaching epidemic levels globally and particulary among Qatar's population(1), there is an urgent need for effective DSME programs that are tailored to the country's needs. Current DSME programs, such as DESMOND-Qatar, have many limitations, including the fact that it is only available in two places, limiting access to many people who could benefit from diabetes education. Furthermore, the certification and recertification of DESMOND educators are rather costly, presenting financial barriers to the scaling up of this model; it is also limited in its long-term effectiveness(2), increasing the need for a sustainable and culturally appropriate solution to enable people with diabetes to self- manage their condition effectively. In this project, I will employ the locally developed PARADIGM model(3) framework to structure the new DSME interventions across two phases. In the initial phase, the focus is on developing a practical working curriculum using this model. This curriculum, named the PARADIGM-Q program, will incorporate the Case-Based Learning (CBL)(4) approach as its teaching delivery method. A systematic review and dose-response meta-analysis of relevant literature related to the optimal characteristics and duration of the program, followed by the development and piloting of the PARADIGM-Q curriculum. The curriculum will be refined through feedback obtained. The second phase involves evaluating the program's effectiveness through a Quasi-Experimental study, comparing it with Qatar's existing Diabetes Education Self-Management for Ongoing and Newly Diagnosed (DESMOND) program. The development of our local novel (PARADIGM-Q) will promote long-term effectiveness and patient adherence by combining the case-based Learning (CBL) approach with PARADIGM model. In addition, it will also emerge as a cost-effective alternative by establishing a central hub for training trainers within the Qatar health system, encompassing PHCC, HMC, Military Health Services, and private sectors. The primary research question is whether a culturally sensitive, case-based DSME program (PARADIGM-Q) can improve clinical and behavioral outcomes more effectively than existing models. This project has the potential to set a new standard for diabetes education in Qatar and the broader Gulf region, offering a scalable, sustainable intervention that aligns with local cultural practices and healthcare needs.
PROJECT STRUCTURE AND RESEARCH APPROACH
OBJECTIVES AND SIGNIFICANCE
Hypothesis:
The primary hypothesis is that implementing a culturally sensitive, case-based and attributes-based diabetes self-management education program (PARADIGM-Q) will significantly improve clinical outcomes, self-management behaviors, and quality of life for people with Type 2 Diabetes Mellitus (T2DM) when compared to the current DESMOND program.
Study Aim:
To Develop a culturally sensitive and well-structured Diabetes Self-Management Education (DSME) Program tailored specifically for individuals with Type 2 Diabetes residing in Qatar. This program will be developed based on the PARADIGM (Problem And attRibutes-bAsed DIabetes self-manaGeMent) model(3).
Objectives
- To Create the curriculum for a culturally sensitive DSME program using Case-Based Learning (CBL) methodology, aligned with the PARADIGM model's core attributes, and tailored to Qatar's cultural variations.
- Pilot study to validate a newly established DSME curriculum for feasibility, comprehensibility, relevance, and cultural sensitivity among diabetes educators and T2DM patients.
- Effectiveness study to determine the impact of the PARADIGM-Q program on clinical outcomes, self-management behaviors, and quality of life compared to the DESMOND program using a robust quasi-experimental design.
METHODOLOGICAL APPROACHES
Type and classification of study:
Several research designs will be used for this study.
Phase One:
Systematic Review Objective: To examine the durability of standard diabetes self-management education program on glycosylated hemoglobin (HbA1c) levels over time, and to identify optimal DSME characteristics for glycemic control, forming the basis for the PARADIGM-Q curriculum.
Methodology: Conduct a rigorous systematic review and dose response meta-analysis of data from existing studies of conventional DSME programs to gather evidence to determine the optimal duration of effect on glycemic control.
Expected Outcome: Synthesize findings to inform on the current baseline before we develop and test our new culturally sensitive DSME program. Our study results will then be compared to results from the evidence synthesis on the durability of current programs on glycemic control.
Curriculum Formulation and Pilot Study Objective: Formulate a core-attributes, problem-based curriculum based on the PARADIGM model, And to collect feedback for refining the curriculum and ensuring it meets the educational and cultural needs of the Qatari population.
Methodology
Design:
- A mixed methods study design will be used and will involve diabetes educators and participants with T2DM in a pilot study to validate the PARADIGM-Q curriculum.
- Utilize focus group, pre-post assessments and semi-structured interviews with participants diagnosed with T2DM and diabetes educators to gather feedback on the curriculum's comprehensibility, relevance, and cultural sensitivity. Subsequently, refine curriculum components based on the insights obtained.
Expected Outcome: A validated and culturally sensitive DSME program curriculum ready for implementation which will be called the PARADIGM-Q program.
Sampling:
- Technique: Non-probability quota sampling
Participants: 20 adults with Type 2 diabetes, divided by gender and language proficiency:
- Male Arabic speakers
- Female Arabic speakers
- Male English speakers
- Female English speakers This is especially relevant as the newly developed (PARADIGM-Q) program aims to address the needs of the multiethnic population residing in Qatar, encompassing individuals proficient in both Arabic and English languages.
Curriculum Contents:
PARADIGM-Q Program Structure:
• Duration: The PARADIGM-Q program consists of three weekly sessions, each lasting three hours, designed to support effective diabetes management by integrating it into daily life routines.
• Session Content:
o Week 1: Problem Solving
o Week 2: Decision Making and Taking Action.
o Week 3: Resource Utilization, and Patient-Provider Relationships
Educational Approach:
• Case-Based Learning (CBL): Each session begins with a case scenario to stimulate discussion, problem-solving, and skills application.
• Interactive Discussions: Each session closes with actionable strategies for taking learned skills back into your daily self-care routine.
• Hands-on Demonstrations: The Facilitator (diabetes educators) aid by using demonstration tools to bridge these gaps.
Data Collection and Analysis
Quantitative Measures:
• Pre- and Post-Program Assessments: Diabetes Knowledge Questionnaire (DKQ), Problem Areas in Diabetes (PAID) Scale, Ambulatory Glucose Profile (AGP) using a glucose sensor for two weeks pre and post the month of the intervention, and physical activity (monitored by smartwatches).
Qualitative Measures:
• Focus Groups: Conducted with T2D participants post-program about the curriculum's relevance, cultural sensitivity, and effectiveness of the educational approach.
- Semi-Structured Interviews: Facilitators and participants will provide insights on session dynamics, instructional methods, and cultural appropriateness.
Data Analysis:
- Quantitative data will be analyzed for knowledge gains, stress reduction (PAID), and glycemic variability.
- Qualitative data will undergo thematic analysis to derive insights into program relevance, effectiveness, and cultural fit.
Expected Outcomes
- A validated, culturally adapted DSME program (PARADIGM-Q) ready for large-scale implementation.
- Qualitative and quantitative evidence of curriculum effectiveness and cultural resonance.
Phase Two:
1- Controlled before-after Quasi-Experimental study Objective: Evaluate the effectiveness of the (PARADIGM-Q) program on various diabetes outcomes among people with T2DM in Qatar.
Expected Outcome: Empirical evidence on the effectiveness of our new culturally sensitive DSME program (PARADIGM-Q) compared to the existing program (DESMOND).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ragae Ahmad Dughmosh, PhD Student
- Phone Number: 55019923
- Email: rd1806208@qu.edu.qa
Study Contact Backup
- Name: Suhail Doi, Professor
- Email: sdoi@qu.edu.qa
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 to 65 years.
- Diagnosed with Type 2 Diabetes Mellitus.
- Most recent HbA1c ≥ 8% (within the last 6 months).
- Fluent in Arabic and/or English.
- Qatari and non-Qatari participants.
- Able and willing to attend group-based education sessions.
Exclusion Criteria:
- Diagnosed with any type of diabetes other than Type 2.
- Pregnant women.
- Presence of major diabetes complications (e.g., renal failure, severe retinopathy, blindness, stroke, heart failure, cancer).
- Physical or mental disabilities that would hinder participation in education sessions.
- Age below 18 or above 65 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PARADIGM-Q Intervention Arm
PARADIGM-Q Intervention Arm (Experimental): Participants in this arm will receive the PARADIGM-Q Diabetes Self-Management Education (DSME) program. This is a culturally sensitive, structured education intervention developed using the PARADIGM model and delivered through Case-Based Learning (CBL). The program consists of three weekly sessions (each lasting 3.5 hours) covering core self-management attributes: problem-solving, decision-making, taking action, resource utilization, and patient-provider relationships. |
PARADIGM-Q Diabetes Self-Management Education Program This is a culturally sensitive, structured education intervention tailored for adults with Type 2 Diabetes in Qatar.
Developed using the PARADIGM model and delivered through a Case-Based Learning (CBL) approach, the program comprises three weekly group sessions of 3.5 hours each.
Each session targets key self-management attributes: problem-solving, decision-making, taking action, resource utilization, and patient-provider relationships.
The program emphasizes real-life applicability, cultural relevance, and skill-building to support sustainable diabetes self-care.
|
|
Active Comparator: DESMOND Control Arm
DESMOND Control Arm (Active Comparator) Participants in this arm will receive the DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) program, which is the standard DSME program currently implemented in Qatar.
It involves two group sessions (each lasting approximately 4 hours) and focuses on providing theoretical-based diabetes education for ongoing and newly diagnosed Type 2 Diabetes patients.
|
The DESMOND Diabetes Self-Management Education Program is the standard diabetes education intervention currently offered to newly diagnosed patients with Type 2 Diabetes in Qatar.
It is a UK-developed, theory-driven program delivered over two group sessions, each lasting approximately four hours.
The program provides structured education on diabetes, lifestyle management, and risk reduction strategies.
It does not incorporate case-based learning or cultural tailoring, distinguishing it from the experimental PARADIGM-Q intervention.
DESMOND is used here as an active comparator to evaluate the added value of culturally sensitive, problem-based education.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Glycated Hemoglobin (HbA1c)
Time Frame: Baseline, 3 months, 6 months, 9 months, 12 months post-intervention
|
Measurement of HbA1c to assess long-term glycemic control.
|
Baseline, 3 months, 6 months, 9 months, 12 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Health-Related Quality of Life
Time Frame: Baseline and 3, 6, 9, 12 months post-intervention
|
Evaluated using the Appraisal of Diabetes Scale (ADS)
|
Baseline and 3, 6, 9, 12 months post-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Manal Musallam Othman, PhD, Hamad Medical Corporation
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ARG02-0403-240132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus (T2DM)
-
Embecta Corp.Jaeb Center for Health ResearchWithdrawnType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | T2DM (Type 2 Diabetes Mellitus) | T2D | T2DM | Type 2 DM | T2DM With Inadequate Glycemic ControlUnited States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Thymia LimitedCompletedType 2 Diabetes | Diabetes (DM) | T2DM (Type 2 Diabetes Mellitus) | T2DMUnited Kingdom
-
University of Colorado, DenverAmerican Academy of Family PhysiciansRecruitingType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | T2DM (Type 2 Diabetes Mellitus) | T2D | T2DM | Artificial Intelegence | Remote Patient MonitoringUnited States
-
Beijing HospitalRecruitingType 2 Diabetic Patients | T2DM (Type 2 Diabetes Mellitus) | T2DMChina
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
Alnylam PharmaceuticalsRecruitingType 2 Diabetes Mellitus (T2DM)United States
-
Xinhua Hospital, Shanghai Jiao Tong University...Not yet recruiting
-
Chipscreen Biosciences, Ltd.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Parc Sanitari Pere VirgiliNot yet recruitingType 2 Diabetes Mellitus (T2DM)Spain
Clinical Trials on Intervention Name: PARADIGM-Q Diabetes Self-Management Education Program
-
Mutah UniversityCompleted
-
Kutahya Health Sciences UniversityCompletedDiabetes Mellitus, Type 2 | Patient Empowerment | EmpowermentTurkey
-
LMC Diabetes & Endocrinology Ltd.Completed
-
Omada Health, Inc.Palo Alto Medical Foundation; Sutter HealthTerminatedType 2 DiabetesUnited States
-
OsakidetzaFondo de Investigacion Sanitaria; Kronikgune-- Association Centre of International... and other collaboratorsCompleted
-
University of MichiganActive, not recruiting
-
University of ArkansasPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2United States
-
University of MichiganNational Institutes of Health (NIH); National Institute on Aging (NIA); Blue...Completed
-
National Institute of Diabetes and Digestive and...CompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
US Department of Veterans AffairsCompletedDiabetes Mellitus Self Management Education | Hyperglycemic Control | High Risk DiabetesUnited States